Value of C-reactive protein as a risk factor for acute coronary syndrome: A comparison with apolipoprotein concentrations and lipid profile

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Krintus, Magdalena ^a   Kozinski, Marek ^a   Stefanska, Anna ^a   Sawicki, Marcin ^a   Obonska, Karolina ^a   Fabiszak, Tomasz ^a   Kubica, Jacek ^a   Sypniewska, Grazyna ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN; LIPID;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; UNSTABLE ANGINA PECTORIS; BLOOD; ELECTROCARDIOGRAPHY; HEART INFARCTION; METABOLISM; MIDDLE AGED; RISK FACTOR;

ANGINA;

ACUTE CORONARY SYNDROME; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-100; APOLIPOPROTEINS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 84869061841     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/419804     Document Type: Article

References (40)

1. Roger V. L., Go A. S., Lloyd-Jones D. M., Benjamin E. J., Berry J. D., Borden W. B., Bravata D. M., Dai S., Ford E. S., Fox C. S., Fullerton H. J., Gillespie C., Hailpern S. M., Heit J. A., Howard V. J., Kissela B. M., Kittner S. J., Lackland D. T., Lichtman J. H., Lisabeth L. D., Makuc D. M., Marcus G. M., Marelli A., Matchar D. B., Moy C. S., Mozaffarian D., Mussolino M. E., Nichol G., Paynter N. P., Soliman E. Z., Sorlie P. D., Sotoodehnia N., Turan T. N., Virani S. S., Wong N. D., Woo D., Turner M. B., Executive summary: heart disease and stroke statistics-2012 update: a report from the American heart association. Circulation 2012 125 1 188 197 2-s2.0-84855353573 10.1161/CIR.0b013e3182456d46
2. Kaptoge S., Di Angelantonio E., Lowe G., C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet 2010 375 9709 132 140 10.1016/S0140- 6736(09)61717-7
3. Swiatkiewicz I., Kozinski M., Magielski P., Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction. Inflammation Research 2012 61 7 725 734 10.1007/s00011-012-0466-2
4. Swiatkiewicz I., Kozinski M., Magielski M., Value of C-reactive protein in predicting left ventricular remodelling in patients with a first ST-segment elevation myocardial infarction. Mediators of Inflammation 2012 2012 11 250867 10.1155/2012/250867
5. Kubica J., Kozinski M., Krzewina-Kowalska A., Zbikowska-Gotz M., Dymek G., Sukiennik A., Piasecki R., Bogdan M., Grzesk G., Chojnicki M., Dziedziczko A., Sypniewska G., Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions. International Journal of Molecular Medicine 2005 16 1 173 180 2-s2.0-23844543663
6. Pearson T. A., Mensah G. A., Alexander R. W., Anderson J. L., Cannon R. O., Criqui M., Fadl Y. Y., Fortmann S. P., Hong Y., Myers G. L., Rifai N., Smith S. C., Taubert K., Tracy R. P., Vinicor F., Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003 107 3 499 511 2-s2.0-0037469232 10.1161/01.CIR.0000052939.59093.45 (Pubitemid 36158056)
7. Wensley F., Gao P., Burgess S., Kaptoge S., Di Angelantonio E., Shah T., Engert J. C., Clarke R., Davey-Smith G., Nordestgaard B. G., Saleheen D., Samani N. J., Sandhu M., Anand S., Pepys M. B., Smeeth L., Whittaker J., Casas J. P., Thompson S. G., Hingorani A. D., Danesh J., Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 2011 342 article d548 2-s2.0-79951993338 10.1136/bmj.d548
8. Bisoendial R. J., Boekholdt S. M., Vergeer M., Stroes E. S. G., Kastelein J. J. P., C-reactive protein is a mediator of cardiovascular disease. European Heart Journal 2010 31 17 2087 2095 2-s2.0-77956398698 10.1093/eurheartj/ehq238
9. Pepys M. B., Hirschfield G. M., Tennent G. A., Gallimore J. R., Kahan M. C., Bellotti V., Hawkins P. N., Myers R. M., Smith M. D., Polara A., Cobb A. J. A., Ley S. V., Aquilina J. A., Robinson C. V., Sharif I., Gray G. A., Sabin C. A., Jenvey M. C., Kolstoe S. E., Thompson D., Wood S. P., Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006 440 7088 1217 1221 2-s2.0-33646366683 10.1038/nature04672
10. Danesh J., Wheeler J. G., Hirschfield G. M., Eda S., Eiriksdottir G., Rumley A., Lowe G. D. O., Pepys M. B., Gudnason V., C-Reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine 2004 350 14 1387 1397 2-s2.0-1842587885 10.1056/NEJMoa032804 (Pubitemid 38419992)
11. Danesh J., Pepys M. B., Editorial: C-reactive protein and coronary disease: is there a causal link? Circulation 2009 120 21 2036 2039 2-s2.0-73449108039 10.1161/CIRCULATIONAHA.109.907212
12. Vaverkova H., Karasek D., Novotny D., Jackuliakova D., Lukes J., Halenka M., Frohlich J., Apolipoprotein B versus LDL-cholesterol: association with other risk factors for atherosclerosis. Clinical Biochemistry 2009 42 12 1246 1251 2-s2.0-67651036211 10.1016/j.clinbiochem.2009.05.004
13. Stone N. J., Reducing residual risk in secondary prevention of cardiovascular disease. Circulation 2012 125 16 1958 1960 10.1161/ CIRCULATIONAHA.112.101782
14. Sypniewska G., Bergmann K., Krintus M., Kozinski M., Kubica J., How do apolipoproteins apoB and apoA-I perform in patients with acute coronary syndromes. Journal of Medical Biochemistry 2011 30 3 237 243 2-s2.0-79959570838 10.2478/v10011-011-0022-6
15. Carnevale Schianca G. P., Pedrazzoli R., Onolfo S., Colli E., Cornetti E., Bergamasco L., Fra G. P., Bartoli E., ApoB/apoA-I ratio is better than LDL-C in detecting cardiovascular risk. Nutrition, Metabolism and Cardiovascular Diseases 2011 21 6 406 411 2-s2.0-79955953580 10.1016/j.numecd.2009.11.002
16. Walldius G., Jungner I., The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapya review of the evidence. Journal of Internal Medicine 2006 259 5 493 519 2-s2.0-33645997399 10.1111/j.1365-2796.2006.01643.x
17. Yusuf P. S., Hawken S., Ôunpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., Lisheng L., Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 364 9438 937 952 2-s2.0-9644262614 10.1016/S0140-6736(04)17018-9 (Pubitemid 39208455)
18. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002 106 25 3143 3421
19. Niccoli G., Biasucci L. M., Biscione C., Fusco B., Porto I., Leone A. M., Bona R. D., Dato I., Liuzzo G., Crea F., Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina. Atherosclerosis 2008 196 2 779 785 2-s2.0-38349084093 10.1016/j.atherosclerosis.2007.01.009
20. Arroyo-Espliguero R., Avanzas P., Cosín-Sales J., Aldama G., Pizzi C., Kaski J. C., C-reactive protein elevation and disease activity in patients with coronary artery disease. European Heart Journal 2004 25 5 401 408 2-s2.0-1642296253 10.1016/j.ehj.2003.12.017 (Pubitemid 38391522)
21. Scirica B. M., Morrow D. A., Cannon C. P., De Lemos J. A., Murphy S., Sabatine M. S., Wiviott S. D., Rifai N., McCabe C. H., Braunwald E., Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. Clinical Chemistry 2007 53 10 1800 1807 2-s2.0-34848865689 10.1373/clinchem.2007.087957 (Pubitemid 47509673)
22. Sheikh A. S., Yahya S., Sheikh N. S., Sheikh A. A., C-reactive protein as a predictor of adverse outcome in patients with acute coronary syndrome. Heart Views 2012 13 1 7 12 10.4103/1995-705X.96660
23. Di Stefano R., Di Bello V., Barsotti M. C., Grigoratos C., Armani C., Dell'Omodarme M., Carpi A., Balbarini A., Inflammatory markers and cardiac function in acute coronary syndrome: Difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models. Biomedicine and Pharmacotherapy 2009 63 10 773 780 2-s2.0-71749107088 10.1016/j.biopha.2009.06. 004
24. Habib S. S., Kurdi M. I., Al Aseri Z., Suriya M. O., CRP levels are higher in patients with ST elevation than non-ST elevation acute coronary syndrome. Arquivos Brasileiros de Cardiologia 2011 96 1 13 17 2-s2.0-79951661715 10.1590/S0066-782X2010005000161
25. Sánchez P. L., Rodríguez M. V., Villacorta E., Albarrán C., Cruz I., Moreiras J. M., Martín F., Pabón P., Fernández-Avilés F., Martín-Luengo C., Kinetics of C-reactive protein release in different forms of acute coronary syndrome. Revista Espanola de Cardiologia 2006 59 5 441 447 2-s2.0-33745319049 10.1157/13087896 (Pubitemid 43949870)
26. Ridker P. M., Danielson E., Fonseca F. A. H., Genest J., Gotto A. M., Kastelein J. J. P., Koenig W., Libby P., Lorenzatti A. J., MacFadyen J. G., Nordestgaard B. G., Shepherd J., Willerson J. T., Glynn R. J., Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine 2008 359 21 2195 2207 2-s2.0-56749106312 10.1056/NEJMoa0807646
27. Kili T., Ural E., Oner G., Which cut-off value of high sensitivity C-reactive protein is more valuable for determining long-term prognosis in patients with acute coronary syndrome? Anadolu Kardiyoloji Dergisi 2009 9 4 280 289 2-s2.0-70349389760
28. Sharma R. K., Singh V. N., Reddy H. K., Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk. Vascular Health and Risk Management 2009 5 793 799 2-s2.0-73349132993
29. Kannel W. B., Vasan R. S., Keyes M. J., Sullivan L. M., Robins S. J., Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort). American Journal of Cardiology 2008 101 4 497 501 2-s2.0-38849106178 10.1016/j.amjcard.2007.09. 109 (Pubitemid 351199440)
30. Cziraky M. J., Watson K. E., Talbert R. L., Stella P., Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Journal of Managed Care Pharmacy 2008 14 8 S3 S28 2-s2.0-56049096263
31. Ray K. K., Cannon C. P., Cairns R., Morrow D. A., Ridker P. M., Braunwald E., Prognostic utility of ApoB/AI, total cholesterol/HDL, Non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes results from PROVE IT-TIMI 22. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 3 423 430 2-s2.0-61549120401 10.1161/ATVBAHA.108.181735
32. McQueen M. J., Hawken S., Wang X., Ounpuu S., Sniderman A., Probstfield J., Steyn K., Sanderson J. E., Hasani M., Volkova E., Kazmi K., Yusuf S., Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. The Lancet 2008 372 9634 224 233 2-s2.0-47149103896 10.1016/S0140-6736(08)61076-4 (Pubitemid 351978112)
33. Shah T., Casas J. P., Cooper J. A., Tzoulaki I., Sofat R., McCormack V., Smeeth L., Deanfield J. E., Lowe G. D., Rumley A., Fowkes F. G. R., Humphries S. E., Hingorani A. D., Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. International Journal of Epidemiology 2009 38 1 217 231 2-s2.0-60149088617 10.1093/ije/dyn217
34. Ridker P. M., Morrow D. A., Rose L. M., Rifai N., Cannon C. P., Braunwald E., Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol 70 mg/dl and C-reactive protein 2 mg/l: An analysis of the PROVE-IT TIMI-22 trial. Journal of the American College of Cardiology 2005 45 10 1644 1648 2-s2.0-18944371407 10.1016/j.jacc.2005.02.080 (Pubitemid 40704500)
35. Williams T. N., Zhang C. X., Game B. A., He L., Huang Y., C-Reactive Protein stimulates MMP-1 expression in U937 histiocytes through fc τ rii and extracellular signal-regulated kinase pathway: an implication of crp involvement in plaque destabilization. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 1 61 66 2-s2.0-0347122997 10.1161/01.ATV.0000104014. 24367.16 (Pubitemid 38082412)
36. Grad E., Pachino R. M., Fitzgerald G. A., Danenberg H. D., Role of thromboxane receptor in C-reactive protein-induced thrombosis. Arteriosclerosis, Thrombosis and Vascular Biology 2012 32 10 2468 2474 10.1161/ATVBAHA.112.256073
37. Raffel O. C., Tearney G. J., Gauthier D. D., Halpern E. F., Bouma B. E., Jang I. K., Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 8 1820 1827 2-s2.0-34547643517 10.1161/ATVBAHA.107.145987 (Pubitemid 47207179)
38. Forte L., Cimmino G., Loffredo F., De Palma R., Abbate G., Calabrò P., Ingrosso D., Galletti P., Carangio C., Casillo B., Calabrò R., Golino P., C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. International Journal of Cardiology 2011 152 1 7 12 2-s2.0-79960564541 10.1016/j.ijcard.2011.05.062
39. Sawicki M., Sypniewska G., Kozinski M., Gruszka M., Krintus M., Obonska K., Pilaczynska-Cemel M., Kubica J., Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes. European Journal of Clinical Investigation 2011 41 6 667 671 2-s2.0-79955613614 10.1111/j.1365-2362.2010. 02457.x
40. Wang T. J., Wollert K. C., Larson M. G., Prognostic utility of novel biomarkers of cardiovascular stress: the framingham heart study. Circulation 2012 126 13 1596 1604